Home > PS Ratio > MARKSANS PHARMA

MARKSANS PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of MARKSANS PHARMA is 3.71.

Share Price ₹172.2Apr 26,2024
Market Cap ₹7,804.1 Cr
Sales-TTM₹2,103.4 CrTTM-Consolidated Results
Price/Sales3.71xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of MARKSANS PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of MARKSANS PHARMA is calculated as :

Current Market Cap [ ₹7,804.1 Cr] as on Apr 26,2024

(/) Sales [ ₹2,103.4 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 3.71x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for MARKSANS PHARMA , the investors are currently willing to pay '3.71 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of MARKSANS PHARMA !

The chart below summarizes the trend in P/S Ratio of MARKSANS PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of MARKSANS PHARMA


PS Ratio Performance Analysis for MARKSANS PHARMA

- MARKSANS PHARMA 's latest p/e ratio is 3.71x.

- MARKSANS PHARMA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.20x.

- MARKSANS PHARMA 's operated at median p/e ratio of 1.25x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MARKSANS PHARMA 's p/e ratio peaked in Mar2023 at 1.72x.

- MARKSANS PHARMA 's p/e ratio hit its five-year low in Mar2020 of 0.5x.


How does MARKSANS PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
MARKSANS PHARMA 2,103.43.717,804.1
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.61360,920.0
CIPLA LTD25,350.24.49113,794.0
DR REDDYS LABORATORIES LTD27,212.53.83104,316.0
ZYDUS LIFESCIENCES LTD19,024.25.0195,380.9
DIVIS LABORATORIES LTD7,492.814.26106,860.0
MANKIND PHARMA LTD9,946.39.5494,869.4
TORRENT PHARMACEUTICALS LTD10,474.08.6991,057.0
LUPIN LTD19,480.13.7873,642.4
AUROBINDO PHARMA LTD27,894.72.3866,278.5
ABBOTT INDIA LTD5,753.49.5554,961.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MARKSANS PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.38x
Max industry PS 14.26x
Median industry PS 5.01x
Average industry PS 6.62x



You may also like the below Video Courses